ArticleOncology research2026

Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism: Association with the circPOLB/miR-548ae-3p/C-MYC Axis.

Liang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.